Table 2.
Author (Reference) | Year | Number of Samples | Blood Collection | Cut off Values for CEA (ng/mL) | p-Value |
---|---|---|---|---|---|
Das et al. [92] | 2007 | 562 | pre-nCRT | ≤2.5 | p = 0.015 |
Yoon et al. [93] | 2007 | 351 | pre-nCRT | ≤5 | p = 0.004 |
Moreno Garcia et al. [94] | 2009 | 148 | pre-nCRT and post-surgery | ≤2.5 | p = 0.05 |
Kalady et al. [95] | 2009 | 242 | Not Reported | ≤2.5 | p = 0.19 |
Park et al. [96] | 2009 | 352 | pre and post-nCRT | ≤3 | p < 0.001 |
Lee et al. [97] | 2009 | 490 | pre-nCRT | ≤5 | p = 0.004 |
Kang et al. [98] | 2010 | 84 | pre and post-nCRT | ≤3 | p = 0.01 |
Aldulaymi et al. [99] | 2010 | 33 | pre-nCRT | ≤5 | p = 0.002 |
Yan et al. [100] | 2011 | 98 | pre-nCRT | ≤3 | p = 0.002 |
Hur et al. [101] | 2011 | 37 | pre-nCRT | ≤3 | p = 0.54 |
Moureau-Zabotto et al. [102] | 2011 | 168 | pre-nCRT | ≤5 | p = 0.019 |
Wallin et al. [103] | 2013 | 267 | pre-nCRT | ≤3.4 | p = 0.008 |
Restivo et al. [104] | 2013 | 260 | pre-nCRT | ≤5 | p = 0.001 |
Lee et al. [105] | 2013 | 345 | pre-nCRT | ≤5 | p = 0.002 |
Huh et al. [22] | 2013 | 391 | pre-nCRT | ≤5 | p = 0.002 |
Yeo et al. [106] | 2013 | 609 | pre-nCRT | ≤5 | p < 0.001 |
Yang et al. [107] | 2013 | 138 | pre-nCRT | ≤6 | p = 0.152 |
Wang et al. [108] | 2014 | 240 | pre-nCRT | ≤5 | p = 0.047 |
Zeng et al. [21] | 2015 | 323 | pre-nCRT | ≤5 | p = 0.007 |
Kim et al. [90] | 2015 | 419 | pre-nCRT | Not Reported | |
Kleiman et al. [109] | 2015 | 141 | pre and post-nCRT | Not Reported | p = 0.003 |
Song et al. [91] | 2016 | 1782 | pre-nCRT | Not Reported | |
Probst et al. [89] | 2016 | 18,113 | pre-nCRT | Not Reported | p < 0.001 |
Abbreviation: nCRT, neoadjuvant chemoradiation; CEA, carcinoembryonic antigen.